Effectiveness and safety of early versus late caffeine therapy in managing apnoea of prematurity among preterm infants: a retrospective cohort study
<h2>Background</h2> <p>Early administration of intravenous (IV) caffeine (initiation within 2 days of life) is an effective treatment strategy for the management of apnoea of prematurity among infants. However, the safety and effectiveness of early administration of oral caffeine t...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , |
| Published: |
2022
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1864513567526486016 |
|---|---|
| author | Won Zi Yun (14151525) |
| author2 | Yaman Walid Kassab (8985716) Liew Mei Yao (14151528) Norliyana Khairuddin (14151531) Long Chiau Ming (9684056) Muhammad Abdul Hadi (3704491) |
| author2_role | author author author author author |
| author_facet | Won Zi Yun (14151525) Yaman Walid Kassab (8985716) Liew Mei Yao (14151528) Norliyana Khairuddin (14151531) Long Chiau Ming (9684056) Muhammad Abdul Hadi (3704491) |
| author_role | author |
| dc.creator.none.fl_str_mv | Won Zi Yun (14151525) Yaman Walid Kassab (8985716) Liew Mei Yao (14151528) Norliyana Khairuddin (14151531) Long Chiau Ming (9684056) Muhammad Abdul Hadi (3704491) |
| dc.date.none.fl_str_mv | 2022-11-22T21:14:12Z |
| dc.identifier.none.fl_str_mv | 10.1007/s11096-022-01437-0 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Effectiveness_and_safety_of_early_versus_late_caffeine_therapy_in_managing_apnoea_of_prematurity_among_preterm_infants_a_retrospective_cohort_study/21597471 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Pharmacology and pharmaceutical sciences Pharmacology (medical) Pharmaceutical Science Pharmacology Toxicology Pharmacy |
| dc.title.none.fl_str_mv | Effectiveness and safety of early versus late caffeine therapy in managing apnoea of prematurity among preterm infants: a retrospective cohort study |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <h2>Background</h2> <p>Early administration of intravenous (IV) caffeine (initiation within 2 days of life) is an effective treatment strategy for the management of apnoea of prematurity among infants. However, the safety and effectiveness of early administration of oral caffeine treatment is not be fully established.</p> <h2>Aim</h2> <p>We aimed to compare the effectiveness and safety of early versus late caffeine therapy on preterm infants’ clinical outcomes.</p> <h2>Method</h2> <p> A retrospective matched cohort study was conducted using data of patients admitted to neonatal intensive care units of two tertiary care hospitals between January 2016 and December 2018. The clinical outcomes and mortality risk between early caffeine (initiation within 2 days of life) and late caffeine (initiation ≥ 3 days of life) were compared. </p> <h2>Results</h2> <p>Ninety-five pairs matched based on gestational age were included in the study. Compared to late initiation, preterm infants with early caffeine therapy had: a shorter duration of non-invasive mechanical ventilation (median 5 days vs. 12 days; p < 0.001); shorter length of hospital stay (median 26 days vs. 44 days; p < 0.001); shorter duration to achieve full enteral feeding (median 5 days vs. 11 days; p < 0.001); and lower frequency of bronchopulmonary dysplasia (BPD) (4.5% vs. 12.9%; p = 0.045). They also had a reduced risk of osteopenia of prematurity (OP) (OR 0.209; 95% CI 0.085–0.509; p = 0.001). </p> <h2>Conclusion</h2> <p>Early oral caffeine therapy can potentially improve respiratory outcomes among infants with apnoea of prematurity. However, an increase in mortality associated with early caffeine therapy requires further investigation.</p><h2>Other Information</h2> <p> Published in: International Journal of Clinical Pharmacy<br> License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1007/s11096-022-01437-0" target="_blank">http://dx.doi.org/10.1007/s11096-022-01437-0</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_cf86cbf71ca395cb6c8368427b0fa714 |
| identifier_str_mv | 10.1007/s11096-022-01437-0 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/21597471 |
| publishDate | 2022 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Effectiveness and safety of early versus late caffeine therapy in managing apnoea of prematurity among preterm infants: a retrospective cohort studyWon Zi Yun (14151525)Yaman Walid Kassab (8985716)Liew Mei Yao (14151528)Norliyana Khairuddin (14151531)Long Chiau Ming (9684056)Muhammad Abdul Hadi (3704491)Pharmacology and pharmaceutical sciencesPharmacology (medical)Pharmaceutical SciencePharmacologyToxicologyPharmacy<h2>Background</h2> <p>Early administration of intravenous (IV) caffeine (initiation within 2 days of life) is an effective treatment strategy for the management of apnoea of prematurity among infants. However, the safety and effectiveness of early administration of oral caffeine treatment is not be fully established.</p> <h2>Aim</h2> <p>We aimed to compare the effectiveness and safety of early versus late caffeine therapy on preterm infants’ clinical outcomes.</p> <h2>Method</h2> <p> A retrospective matched cohort study was conducted using data of patients admitted to neonatal intensive care units of two tertiary care hospitals between January 2016 and December 2018. The clinical outcomes and mortality risk between early caffeine (initiation within 2 days of life) and late caffeine (initiation ≥ 3 days of life) were compared. </p> <h2>Results</h2> <p>Ninety-five pairs matched based on gestational age were included in the study. Compared to late initiation, preterm infants with early caffeine therapy had: a shorter duration of non-invasive mechanical ventilation (median 5 days vs. 12 days; p < 0.001); shorter length of hospital stay (median 26 days vs. 44 days; p < 0.001); shorter duration to achieve full enteral feeding (median 5 days vs. 11 days; p < 0.001); and lower frequency of bronchopulmonary dysplasia (BPD) (4.5% vs. 12.9%; p = 0.045). They also had a reduced risk of osteopenia of prematurity (OP) (OR 0.209; 95% CI 0.085–0.509; p = 0.001). </p> <h2>Conclusion</h2> <p>Early oral caffeine therapy can potentially improve respiratory outcomes among infants with apnoea of prematurity. However, an increase in mortality associated with early caffeine therapy requires further investigation.</p><h2>Other Information</h2> <p> Published in: International Journal of Clinical Pharmacy<br> License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1007/s11096-022-01437-0" target="_blank">http://dx.doi.org/10.1007/s11096-022-01437-0</a></p>2022-11-22T21:14:12ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1007/s11096-022-01437-0https://figshare.com/articles/journal_contribution/Effectiveness_and_safety_of_early_versus_late_caffeine_therapy_in_managing_apnoea_of_prematurity_among_preterm_infants_a_retrospective_cohort_study/21597471CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/215974712022-11-22T21:14:12Z |
| spellingShingle | Effectiveness and safety of early versus late caffeine therapy in managing apnoea of prematurity among preterm infants: a retrospective cohort study Won Zi Yun (14151525) Pharmacology and pharmaceutical sciences Pharmacology (medical) Pharmaceutical Science Pharmacology Toxicology Pharmacy |
| status_str | publishedVersion |
| title | Effectiveness and safety of early versus late caffeine therapy in managing apnoea of prematurity among preterm infants: a retrospective cohort study |
| title_full | Effectiveness and safety of early versus late caffeine therapy in managing apnoea of prematurity among preterm infants: a retrospective cohort study |
| title_fullStr | Effectiveness and safety of early versus late caffeine therapy in managing apnoea of prematurity among preterm infants: a retrospective cohort study |
| title_full_unstemmed | Effectiveness and safety of early versus late caffeine therapy in managing apnoea of prematurity among preterm infants: a retrospective cohort study |
| title_short | Effectiveness and safety of early versus late caffeine therapy in managing apnoea of prematurity among preterm infants: a retrospective cohort study |
| title_sort | Effectiveness and safety of early versus late caffeine therapy in managing apnoea of prematurity among preterm infants: a retrospective cohort study |
| topic | Pharmacology and pharmaceutical sciences Pharmacology (medical) Pharmaceutical Science Pharmacology Toxicology Pharmacy |